PET Manufacturer Hit for Numerous Violations

Drug Industry Daily
A A
The FDA cited the University of Texas Southwestern Medical Center for significant violations at its positron emission tomography (PET) drug manufacturing facility in Dallas.

To View This Article:

Login

Subscribe To Drug Industry Daily